Correlation Between Beta Drugs and India Tourism

Can any of the company-specific risk be diversified away by investing in both Beta Drugs and India Tourism at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and India Tourism into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beta Drugs and India Tourism Development, you can compare the effects of market volatilities on Beta Drugs and India Tourism and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of India Tourism. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and India Tourism.

Diversification Opportunities for Beta Drugs and India Tourism

0.78

Correlation Coefficient

Beta Drugs  India Tourism

Poor diversification

The 3 months correlation between Beta and India is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and India Tourism Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on India Tourism Development and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with India Tourism. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of India Tourism Development has no effect on the direction of Beta Drugs i.e., Beta Drugs and India Tourism go up and down completely randomly.

Pair Corralation between Beta Drugs and India Tourism

Assuming the 90 days trading horizon Beta Drugs is expected to generate 7.33 times less return on investment than India Tourism. But when comparing it to its historical volatility, Beta Drugs is 1.24 times less risky than India Tourism. It trades about 0.0 of its potential returns per unit of risk. India Tourism Development is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  60,665  in India Tourism Development on December 30, 2024 and sell it today you would lose (1,830) from holding India Tourism Development or give up 3.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Beta Drugs  vs.  India Tourism Development

Beta Drugs

Risk-Adjusted Performance

Very Weak

Over the last 90 days Beta Drugs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Beta Drugs is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

India Tourism Development

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in India Tourism Development are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, India Tourism is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Beta Drugs and India Tourism

The main advantage of trading using opposite Beta Drugs and India Tourism positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, India Tourism can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in India Tourism will offset losses from the drop in India Tourism's long position.

The idea behind Beta Drugs and India Tourism Development pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.